Bladder Cancer

Gemcitabine May Hold Promise for BCG Failures in Bladder Cancer Patients

Jody A. Charnow February 25, 2010

Gemcitabine might be a second-line treatment option for patients with high-risk non-muscle-invasive bladder cancer (BC) who fail therapy with bacille Calmette-Guérin (BCG), according to Italian researchers.
 

BCG Superior For Treating Bladder Cancer

Jody A. Charnow February 16, 2010

BCG cut the risk of cancer-related death risk by 53% versus epirubicin.
 

Lymphovascular Invasion Predicts Worse Outcomes

Jody A. Charnow February 16, 2010

It is associated with a higher risk of recurrence and death from upper tract urothelial carcinoma.
 

Benign Prostatic Hyperplasia

BPH Again Linked to Inflammation

Jody A. Charnow February 22, 2010

The condition is more likely to develop in men with high interleukin-6 or C-reactive protein levels.
 

CKD in Men With BPH-Related LUTS

Jody A. Charnow December 15, 2009

Decreased peak flow rate and a history of hypertension and/or diabetes are significantly associated with CKD in men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH), according to investigators in Seoul, Korea.
 

BPH Drug May Raise Testosterone

Jody A. Charnow November 19, 2009

Dutasteride treatment for benign prostatic hyperplasia (BPH) is associated with a significant increase in serum testosterone and a significant decrease in BMI among men with relatively lower baseline serum testosterone levels, researchers reported in BJU International (2009; published online ahead of print).
 

Erectile Dysfunction

Erectile Dysfunction, Restless Leg Syndrome Linked

Delicia Honen Yard January 20, 2010

Older men with restless leg syndrome (RLS) are more likely to have erectile dysfunction (ED) than men without RLS—and dopamine may be the common denominator, according to a study.
 

Severe Erectile Dysfunction Less Likely in Blacks and Asians

Jody A. Charnow January 15, 2010

Black men and Asian men are less likely to have severe erectile dysfunction (ED) than white men, according to a study of 78,445 men aged 45 to 69 years who were not diagnosed with prostate cancer.
 

Shock Wave Therapy Found to Relieve ED

Jill Stein January 01, 2010

LYON, FRANCE—Israeli researchers have reported promising preliminary results using low-intensity shock wave therapy to treat vasculogenic erectile dysfunction (ED).
 

Drug Found to Benefit Men With Peyronie's Disease

Jody A. Charnow December 15, 2009

Pentoxifylline sustained-release (PTX-SR) is moderately effective reducing penile curvature and plaque volume in men suffering from early Peyronie's disease, researchers concluded.
 

ED, Rheumatoid Arthritis Could Be Linked

Jill Stein December 10, 2009

PHILADELPHIA—Erectile dysfunction (ED) is more common in patients with rheumatic disease—especially rheumatoid arthritis (RA)—than in the general population, according to new findings by an Irish research team.
 

Kidney Cancer

Renal Cell Carinoma Type Tied to Time on Dialysis

Jody A. Charnow March 02, 2010

The histologic type of renal cell carcinoma (RCC) arising in patients with end-stage renal disease (ESRD) may be related to the time on dialysis, according to a study.
 

Excellent Short-Term Outcomes Reported for RAPN

Jody A. Charnow March 02, 2010

Robot-assisted partial nephrectomy (RAPN) is a safe and effective approach for nephron-sparing surgery (NSS) that is capable of providing patients with excellent short-term oncologic outcomes, according to the largest RAPN experience described to date.
 

Pre-Nephrectomy Sorafenib Shrinks Renal Cancer Tumors

John Schieszer February 25, 2010

Administering sorafenib prior to nephrectomy for renal cell carcinoma (RCC) can reduce the size of the primary tumor with adding to the risk of surgery, according to researchers at the University of North Carolina at Chapel Hill.
 

Kidney Stones

Kidney Stone Disease Tied to Obesity

Jody A. Charnow February 16, 2010

During a five-year period, stones were diagnosed in 4.9% of obese and 2.6% of non-obese subjects.
 

Study Identifies Predictors of CKD in Stone Formers

Jody A. Charnow January 15, 2010

Diabetes, hypertension, frequent UTIs, the formation of struvite stones, and allopurinol use may predict the development of CKD among individuals who have had kidney stones, researchers reported in the American Journal of Kidney Diseases (2009; published online ahead of print).
 

Study Identifies Predictors of CKD in Stone Formers

Jody A. Charnow November 23, 2009

Among individuals who have had kidney stones, diabetes, hypertension, frequent UTIs, the formation of struvite stones, and allopurinol use may predict the development of CKD, according to researchers.
 

Lithostat for Struvite Stones Reintroduced

Jody A. Charnow November 19, 2009

Lithostat (acetohydroxamic acid), the only urease inhibitor available for urea-splitting urinary infections in association with struvite stones, is available again at pharmacies nationwide, according to the drug's marketer, Mission Pharmacal.
 

Healthy Diet May Lower Kidney Stone Risk

Jody A. Charnow October 16, 2009

The protective effect of a DASH-style diet was similar for men and women regardless of age and BMI.
 

Overactive Bladder

Study: Most OAB Cases Go Untreated

Jody A. Charnow February 05, 2010

The associated cost is a potential reason for undertreatment.
 

Study: Most Overactive Bladder Cases Go Untreated

Jody A. Charnow January 11, 2010

Only 24.4% of patients aged 45 years and older take drugs for the condition, according to researchers.
 

PTNS Provides Sustained Overactive Bladder Relief

Jill Stein November 19, 2009

Study findings at 12 months showed prolonged significant improvements in objective urinary parameters.
 

OAB Meds Not Equal When It Comes To Adverse Effects

Rosemary Frei, MSc October 22, 2009

Solifenacin-treated patients experienced less dry mouth than those taking oxybutynin immediate release.
 

Nerve Stimulation An Overactive Bladder Option

Jody A. Charnow September 17, 2009

Percutaneous tibial nerve stimulation may be considered an alternative treatment for overactive bladder (OAB), researchers reported in the Journal of Urology (2009;182:1055-1061).
 

Premature Ejaculation

Topical Spray for PE Safe, Effective

John Schieszer August 19, 2009

Men suffering from premature ejaculation had a sixfold increase in intravaginal ejaculatory time.
 

Drug Works for Premature Ejaculation

Jody A. Charnow March 06, 2009

Dapoxetine shows efficacy in the treatment of premature ejaculation (PE), according to a new study that researchers say is the most comprehensive to date examining a pharmacologic treatment for PE.
 

Expert Panel Defines Premature Ejaculation

John Schieszer August 28, 2008

ORLANDO—For the first time, clinicians have an evidence-based definition of premature ejaculation (PE).
 

Premature Ejaculation Gets Evidence-Based Definition

Jody A. Charnow June 03, 2008

A panel of sexual health authorities has developed what they say is the first evidence-based definition of premature ejaculation (PE).
 

PE Treatment Means Better Sex for Women

Jill Stein May 01, 2008

MILAN—Female partners of men with premature ejaculation (PE) seem to benefit when the condition is treated with dapoxetine (DPX), according to findings presented here at the European Association of Urology 23rd Congress.
 

Prostate Cancer

Chemo May Improve Survival in Men with Advanced PCa on ADT

Jody A. Charnow March 10, 2010

SAN FRANCISCO—Chemotherapy is associated with a significantly decreased risk of death from prostate cancer (PCa) among elderly men with Stage IV prostate cancer treated with androgen deprivation therapy (ADT), new findings suggest.
 

Dietary Fat and Prostate Cancer Risk

Delicia Honen Yard March 09, 2010

Studies provide conflicting results on the influence of dietary fat, but caloric intake may be the key, researcher says.
 

PSM Linked to Obesity in Men with Locally Advanced Prostate Cancer

Jody A. Charnow March 08, 2010

SAN FRANCISCO—Obesity is associated with higher positive surgical margin (PSM) rates after robotic-assisted laparoscopic prostatectomy (RALP), a study found.
 

Death After Prostatectomy Seldom Due to Prostate Cancer

Jody A. Charnow March 07, 2010

SAN FRANCISCO—Cumulative mortality from prostate cancer 15 years after radical prostatectomy is six times lower than death from other causes, according to study findings presented here at the Genitourinary Cancers Symposium. Among men older than 65 years at the time of surgery, cumulative 15-year mortality is 10 times lower.
 

Most Skeletal-Related Events Due to Bony Metastases

Jody A. Charnow March 07, 2010

SAN FRANCISCO—Skeletal-related events (SREs) in patients with metastatic hormone-refractory prostate cancer (mHRPC) are mostly due to bony metastatic disease and not decreased bone mineral density (BMD), according to British researchers.
 

Prostate Specific Antigen

PCA3 Beats PSA in Predicting Prostate Biopsy Outcomes

Jody A. Charnow March 05, 2010

SAN FRANCISCO—The prostate cancer gene 3 (PCA3) molecular urine test is more accurate than the PSA test in predicting outcomes of repeat biopsies, new findings confirm.
 

PSA Levels Decline After The Start of Statin Therapy

Jody A. Charnow January 15, 2010

Onset of statin use is associated with a significant reduction in serum PSA level, data suggest.
 

PSA Testing Rate Highest in Blacks

Jody A. Charnow December 15, 2009

A study of a large multiethnic cohort found that African-American men had a higher prevalence of PSA screening than white and Latino men.
 

Undetectable PSA Possible With Radiation

John Schieszer December 10, 2009

After a median of 32 months, PSA was undetectable in 12% of patients.
 

BMI Affects PSA Test Results in Whites

Jody A. Charnow September 18, 2009

The likelihood of an abnormal finding is 46% lower in obese men than normal-weight men, study shows
 

Reproductive Medicine

Hypogonadism Linked to Statin Use

Jody A. Charnow February 17, 2010

Statin therapy may induce primary hypogonadism and should be considered a possible confounding factor when evaluating testosterone levels in patients with erectile dysfunction (ED), according to Italian researchers.
 

Circumcision Offers Little Clinical Benefit

Delicia Honen Yard February 16, 2010

Adult circumcision appears to have little clinical benefit in terms of preventing urinary tract infections, sexual transmitted diseases, and penile cancer, according to a systematic review of eight studies.
 

Vasectomy Reversal With Robotic Help

John Schieszer February 05, 2010

Single-surgeon series shows it can decrease operative time compared with traditional procedures.
 

AUA Creates Circumcision Task Force

January 26, 2010

The American Urological Association (AUA) has formed a Male Circumcision Task Force and is collaborating with major international health care agencies to bolster adult male circumcision services in sub-Saharan Africa to combat the spread of AIDS.
 

Retrieved Sperm No Better Than Ejaculated Sperm

John Schieszer January 15, 2010

Men with severe oligoasthenospermia may be able to avoid testicular sperm retrieval, data suggest.
 

Urinary Incontinence

Transobturator Sling Improves Treatment of Female Stress Urinary Incontinence

Jill Stein November 19, 2009

Before surgery, 6% of women tested negative on the cough stress test compared with 98% at 12 months .
 

Botulinum Toxin Injections Ease Refractory Incontinence

Jill Stein November 06, 2009

Four weeks after treatment, 51% of subjects had complete continence.
 

Transobturator Sling Improves Treatment of Female Stress Urinary Incontinence

Jill Stein October 22, 2009

Before surgery, 6% of women tested negative on the cough stress test compared with 98% at 12 months .
 

Injections Ease Refractory Incontinence

Jill Stein October 22, 2009

Intradetrusor injections of botulinum toxin type A may be an effective treatment for refractory idiopathic detrusor overactivity.
 

Electrical Stimulation Provides Sustained OAB Relief

Jill Stein October 22, 2009

Study findings at 12 months showed prolonged significant improvements in objective urinary parameters.
 

Urinary Tract Infections

Post-Op Infectious Complications Characterized

Jody A. Charnow March 02, 2010

The problems developed following 20% of major urologic procedures in patients with chronic bacteriuria.
 

Oral Drug Is An Appropriate Option for Resistant UTIs

John Schieszer November 19, 2009

In a study, only 3% of ESBL-producing Escherhicia coli isolates were resistant to fosfomycin.
 

Antibiotic UTI Prophylaxis Slightly Better

John Schieszer November 19, 2009

It is associated with fewer recurrences than lactobacilli, but it increases antibiotic resistance.
 

Bacteria Interference May Prevent Urinary Tract Infections

John Schieszer November 19, 2009

A non-pathogenic strain of E. coli lowered the UTI rate in catheterized men with neurogenic bladder.
 

Using Bacteria to Prevent Urinary Tract Infections

John Schieszer October 02, 2009

A non-pathogenic strain of E. coli lowered the UTI rate in catheterized men with neurogenic bladder.
 
 Subscribe to the RSS for this page  [view all our RSS feeds here]